Back to search

Article

Immunological and clinicopathological characteristics of C1RL in 2120 glioma patients

2020-07-29

Abstract excerpt

<h4>Background: </h4> Glioma is a deadly and immunosuppressive brain tumour. Complement C1r subcomponent like (C1RL), a prognostic biomarker in several kinds of tumours, has attracted increasing attention from oncologists. However, the role of C1RL in glioma remains unclear. Methods Through analysis of 2120 glioma patients from 5 public datasets, the relationships between C1RL expression and clinicopathological ch...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3f5732b6-4bf8-5a50-a5da-73ccb700bec5
DOI
10.21203/rs.3.rs-26895/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Immunological and clinicopathological characteristics of C1RL in 2120 glioma patientsDOI 10.21203/rs.3.rs-26895/v2
The Predictive and Therapeutic Role of Complement in GliomasSemantic proximity
Bioinformatics Analysis of C3 in Brain Low Grade Gliomas as Potential Therapeutic Target and Promoting Immune Cell InfiltrationSemantic proximity
Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapySemantic proximity
Molecular and clinical characterization of IDH associated immune signature in lower-grade gliomasSemantic proximity
A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in GliomaSemantic proximity
Immune landscape of isocitrate dehydrogenase stratified human gliomasSemantic proximity
Inflammatory expression profiling defines the tumor microenvironment and immunity in lower-grade gliomasSemantic proximity
UBE2C is associated with Prognosis of Immunosuppression and Cell Invasiveness in GliomaSemantic proximity
Molecular characterization and clinical relevance of RCAN1 in diffuse gliomasSemantic proximity
A Comprehensive Bioinformatic Analysis of RFC1/2/3/4/5 As Significant Clinical Indicators in The Diagnosis and Prognosis of Low-Grade GliomaSemantic proximity
Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade gliomaSemantic proximity
ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppressionSemantic proximity
Select a neighboring publication to make it the new centre.